Physician profile
Alexander Gotesman
NPI 1003002072
$921.92
in general payments reported to CMS, 2019-2025
13 companies · $45.10 in 2025
The $45.10 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $190 · 2021: $64.15 · 2022: $163 · 2023: $99.54 · 2024: $150 · 2025: $45.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $329.42 | 2021-2024 | Interstim |
| Astellas Pharma US INC | $203.93 | 2019-2020 | |
| Neotract INC. | $112.80 | 2019-2020 | |
| Medtronic USA, INC. | $65.61 | 2019 | |
| Ambu INC. | $43.22 | 2023 | |
| Olympus America INC. | $42.15 | 2021-2025 | Itind System |
| Boston Scientific Corporation | $33.51 | 2021 | |
| Endo Pharmaceuticals INC. | $17.46 | 2019 | |
| Coloplast Corp | $17.25 | 2025 | |
| Antares Pharma, INC. | $17.21 | 2022 | |
| Myriad Genetic Laboratories, INC. | $13.75 | 2022 | |
| Abbvie INC. | $13.53 | 2022 | |
| Rochester Medical Corporation | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Gotesman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.